News

California judge orders Johnson & Johnson to pay $344 million in pelvic mesh claims

This page features: Cited Research Articles On Thursday, January 30th, a judge in San Diego, California, ordered Johnson & Johnson to pay $344 million to plaintiffs in a case of false and deceptive marketing of their pelvic mesh products. These products are by tens of thousands of women in the state.  The lawsuit was another blow …

California judge orders Johnson & Johnson to pay $344 million in pelvic mesh claims Read More »

Teva Pharmaceuticals sells its product Paragard for $1.1B while active lawsuits are being filed

This page features: Cited Research Articles The Paragard is an intrauterine device (IUD) that is used by women as a form of contraception. An IUD is considered to be one of the most effective forms of contraceptives because once it is inserted by a healthcare professional, it requires little compliance for it to be effective.  It …

Teva Pharmaceuticals sells its product Paragard for $1.1B while active lawsuits are being filed Read More »

Strong link indicates a link between hair dye, chemical straighteners, and breast cancer

This page features: Cited Research Articles Hair dying, whether to enhance a natural color or to hide grays, is ubiquitous in American culture, but a recent study published in the International Journal of Cancer showing a possible link between breast cancer and the use of hair dye and chemical straighteners, especially among African American women, could have people …

Strong link indicates a link between hair dye, chemical straighteners, and breast cancer Read More »

Cardinal Health Announces Voluntary Recall of Potentially Contaminated Surgical Gowns

This page features: Cited Research Articles Cardinal Health announced on Jan. 30, 2020, that it had terminated business with Siyang Holymed in Suqian, China. This termination came after the supplier outsourced some of its surgical gowns to a non-qualified facility lacking proper quality control standards for sterility. After Cardinal Health terminated its contract with Siyang Holymed, …

Cardinal Health Announces Voluntary Recall of Potentially Contaminated Surgical Gowns Read More »

FDA Issues Safety Warning Due to Increased Death Rates From Febuxostat

This page features: Cited Research Articles In February of 2019, the FDA issued a new black box warning for the medication febuxostat, which users currently take for gout. The warning states that patients who take the drug are at an increased risk of death due to heart related complications. A recent report showed 15 recent deaths …

FDA Issues Safety Warning Due to Increased Death Rates From Febuxostat Read More »